Price $51.67 |
Market Cap
7.12B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
96.7
|
P/B
9.56
|
P/S
11.98
|
Dividend %
-
|
|
P/CF
9.8
|
P/FCF
12.6
|
Op. Cash Flow
562.5K
|
FCF
4.1
|
|
Op. Margin
-8.80%
|
Net Margin
-7.20%
|
ROE
-10.10%
|
ROI
14.60%
|
|
ROA
-2.60%
|
EPS Growth
-221.10%
|
Current Ratio
4.8
|
Debt/Equity
215.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Sangamo Therapeutics Inc (SGMO) | $11.21 | - | - | 1.42B | Strong Buy |
| InfuSystem Holdings Inc (INFU) | $3.35 | - | - | 61.1M | Strong Buy |
| Correvio Pharma Corp (CORV) | $3.14 | - | - | 122.4M | Strong Buy |
| Aquinox Pharmaceuticals Inc (AQXP) | $2.16 | - | - | 63.8M | Strong Buy |
| Quorum Health Corp (QHC) | $4.03 | - | - | 140.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
